You are currently browsing:

FDA approves Atezolizumab for Triple-Negative Breast Cancer

The US FDA has granted accelerated approval of a new treatment for triple-negative breast cancer, which is difficult to treat. Further trials are required, but early studies strongly suggest that patients with triple-negative breast cancer benefit from this combination treatment. For further details, click on the link below: https://www.cancer.gov/news-events/cancer-currents-blog/2019/atezolizumab-triple-negative-breast-cancer-fda-approval?fbclid=IwAR00ZVHpsrp2qMMLx1Z9stNVarNL9Hqs_9WcpWrSO4vgYWFYqZKSKtpYepc     

Read More

Mortality rates from breast cancer in Europe predicted to fall in 2019

According to a study published in the journal, Annals of Oncology, mortality rates from breast cancer are predicted to fall across Europe in 2019 thanks to improvements in screening, early diagnosis and treatment. Breast Cancer Ireland hopes that with more research, mortality rates will continue to decrease in the coming years. For further details, please […]

Read More

Leopardstown Race Event Supporting Breast Cancer Ireland

Leopardstown Racecourse continues to support Breast Cancer Ireland by hosting their Ladies Evening this year on Friday, May 17. This is the third time this event – also supported by Microsoft – is being held in aid of Breast Cancer Ireland. The exclusive evening will feature champagne, food, entertainment, and moving speeches from keynote speakers […]

Read More

3D Mammography could transform breast cancer screening and save thousands from unnecessary biopsies

Breast Cancer Ireland applauds this study from the Leeds Teaching Hospitals NHS Trust, which shows that a pioneering 3D mammogram technique could halve the number of women unnecessarily sent for potentially painful breast biopsies. For more information, please click on the below link: https://www.telegraph.co.uk/science/2019/03/19/3d-mammography-could-transform-breast-cancer-screening-save/?fbclid=IwAR23CXD6cru1NZ9Vy1VYqICGyENIJZXP9viOMjWYdojzqYfhgOQW42o6HQ0

Read More

Cancer’s ‘internal wiring’ predicts relapse risk

Breast Cancer Ireland is in full support of this study by scientists at Stanford University and the University of Cambridge. The study not only helps inform women of their future risk of breast cancer but may also change the way their cancers are treated. For more information on this development, please click the link below: […]

Read More
X